GlassScriptPhysician profile
Matthew R Tolley
NPI 1336152446
$2,645.00
in general payments reported to CMS, 2019-2025
27 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $159 · 2021: $391 · 2022: $468 · 2023: $319 · 2024: $543 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053 · Travel and Lodging: $16.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.19 |
| Travel and Lodging | $16.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,029.60 | 2019-2025 | Puraply, Puraply Franchise, Simplimax |
| Smith+Nephew, INC. | $368.26 | 2019-2024 | Collagenase Santyl, Renasys Go V2 Home, Bone Anchors With Arthroscopic Delivery System |
| Paratek Pharmaceuticals, INC. | $248.06 | 2021-2025 | Nuzyra |
| Nevro Corp. | $133.50 | 2022-2024 | Senza |
| Keswick Pharmaceuticals LLC | $112.95 | 2019 | |
| Kerecis Limited | $83.80 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Stryker Corporation | $83.00 | 2019-2023 | Anchorage |
| Treace Medical Concepts, INC. | $65.13 | 2024-2025 | |
| Nabriva Therapeutics, Plc | $55.95 | 2021-2022 | |
| Horizon Therapeutics Plc | $53.48 | 2019-2022 | |
| Melinta Therapeutics, LLC | $45.71 | 2019 | |
| Depuy Synthes Sales INC. | $45.24 | 2022 | |
| Kci USA, INC. | $39.41 | 2019-2021 | |
| Convatec INC. | $31.77 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $30.96 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $25.00 | 2019 | |
| Grt US Holding, INC. | $23.39 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.78 | 2021 | |
| Biocomposites INC | $21.26 | 2021 | |
| Heron Therapeutics, INC. | $20.30 | 2021 | |
| Hartmann USA, INC. | $18.98 | 2021 | |
| Zyla Life Sciences, INC. | $17.94 | 2020 | |
| Wright Medical Technology, INC. | $16.41 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $16.05 | 2023 | |
| Integra Lifesciences Corporation | $12.88 | 2020 | |
| Alfasigma USA, INC. | $11.71 | 2022 | |
| Merck Sharp & Dohme LLC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Tolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.